Analysis of autopsy evaluations of ovarian cancer patients treated at the National Cancer Institute, 1972-1988

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 23, Issue 2, 2000, Pages 107-116

  Reed, Eddie ^a   Zerbe, Christa S ^a   Brawley, Otis W ^a   Bicher, Annette ^a   Steinberg, Seth M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Autopsy; Cisplatin; Ovarian cancer

Indexed keywords

CISPLATIN; PLATINUM DERIVATIVE;

ADRENAL METASTASIS; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MAJOR CLINICAL STUDY; OVARY CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; ANTINEOPLASTIC AGENTS; AUTOPSY; CISPLATIN; COHORT STUDIES; DEMOGRAPHY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0033637674     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200004000-00002     Document Type: Article

References (23)

1. Cancer of the ovary
2. The chemotherapy of ovarian cancer
3. Metastatic patterns in histologic variants of ovarian cancer: An autopsy study
4. Distribution of disease at autopsy in 100 women with ovarian cancer
5. Carcinoma of the ovary. A clinicopathological study of 86 autopsied cases with special reference to mode of spread
6. Obstet Gynecol
7. Involvement of the central nervous system by ovarian carcinoma
8. A study on the distribution of metastases at autopsy in 70 patients with ovarian cancer
9. Nonparametric estimation from incomplete observations
10. Long term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma
11. Chemotherapy of ovarian cancer
12. Prospective trial of melphalan (L-PAM) versus combination chemotherapy (Hexa-CAF) in ovarian adenocarcinoma
13. Enhanced malignant conversion of benign mouse skin tumors by cisplatin
14. Cisplatin and platinum analogs
15. Platinum analogues
16. Platinum analogs
17. Acute leukemia following cisplatin-based chemotherapy in a patient with ovarian cancer
18. Acute leukemia following cisplatin for bladder cancer
19. Cisplatin
20. A preliminary risk-benefit assessment of paclitaxel
21. Paclitaxel (Taxol)
22. In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems
23. Synergistic interaction between cisplatin and gemcitabine in vitro